Latest debt-to-equity ratio
Tarsus Pharmaceuticals Debt-to-equity ratio
Direct answer
Tarsus Pharmaceuticals's debt-to-equity ratio is 25.61%.
The verified market snapshot reports 25.61%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 25.61%
Explore related company data
View Tarsus Pharmaceuticals's market capitalizationView Tarsus Pharmaceuticals's price-to-book ratioView Tarsus Pharmaceuticals's return on equityView Tarsus Pharmaceuticals's dividend yieldView Tarsus Pharmaceuticals's 52-week price rangeView Tarsus Pharmaceuticals's revenue growthView Tarsus Pharmaceuticals's profit marginView all Tarsus Pharmaceuticals key metricsReturn to Tarsus Pharmaceuticals profile